JENNIFER MILLADO: Open Payments
NPI 1558649137 · PHILA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,773 in 114 payments from 18 companies in 2025. Trend: 2023 $1,848 · 2024 $2,665 · 2025 $2,773
Food & beverage: $2,773
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $466 |
| Novo Nordisk Inc | 8 | $309 |
| Dexcom, Inc. | 7 | $273 |
| Boston Scientific Corporation | 22 | $231 |
| GlaxoSmithKline, LLC. | 13 | $223 |
| Exact Sciences Corporation | 7 | $222 |
| PFIZER INC. | 11 | $181 |
| Amgen Inc. | 5 | $176 |
| Abbott Laboratories | 1 | $151 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $126 |
Products named: MOUNJARO, Ozempic, WATCHMAN FLX, JARDIANCE, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, DEXCOM G7 GSS (161).
Industry payments across PA — which companies pay providers there.
